Literature DB >> 25701854

Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study.

Anthony D Bai1, Adrienne Showler2, Lisa Burry3, Marilyn Steinberg4, Daniel R Ricciuto5, Tania Fernandes6, Anna Chiu6, Sumit Raybardhan7, Michelle Science8, Eshan Fernando2, George Tomlinson9, Chaim M Bell10, Andrew M Morris11.   

Abstract

BACKGROUND: We assessed the impact of infectious disease (ID) consultation on management and outcome in patients with Staphylococcus aureus bacteremia (SAB).
METHODS: A retrospective cohort study examined consecutive SAB patients from 6 academic and community hospitals between 2007 and 2010. Quality measures of management including echocardiography, repeat blood culture, removal of infectious foci, and antibiotic therapy were compared between ID consultation (IDC) and no ID consultation (NIDC) groups. A competing risk model with propensity score adjustment was used to compare in-hospital mortality and time to discharge.
RESULTS: Of 847 SAB patients, 506 (60%) patients received an ID consultation and 341 (40%) patients did not. Echocardiography was done for 371 (73%) IDC and 191 (56%) NIDC patients (P < .0001) in hospital. Blood cultures were repeated within 2-4 days of bacteremia in 207 (41%) IDC and 107 (31%) NIDC patients (P = .0058). The infectious foci removal rate was not statistically different between the 2 groups. For empiric therapy, 474 (94%) IDC and 297 (87%) NIDC patients received appropriate antibiotics (P = .0013). For patients who finished the planned course of antibiotics, 285 of 422 (68%) IDC and 141 of 262 (54%) NIDC patients received the appropriate duration of antibiotic therapy (P = .0004). In hospital, 204 (24%) patients died: 104 of 506 (21%) IDC and 100 of 341 (29%) NIDC patients. Matched by propensity score, ID consultation had a subdistribution hazard ratio of 0.72 (95% confidence interval [CI], .52-.99; P = .0451) for in-hospital mortality and 1.28 (95% CI, 1.06-1.56; P = .0109) for being discharged alive.
CONCLUSIONS: ID consultation is associated with better adherence to quality measures, reduced in-hospital mortality, and earlier discharge in patients with SAB.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Staphylococcus aureus; bacteremia; infectious disease consultation; mortality; quality of care

Mesh:

Year:  2015        PMID: 25701854     DOI: 10.1093/cid/civ120

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  71 in total

1.  Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.

Authors:  Nicholas S Britt; Emily M Potter; Nimish Patel; Molly E Steed
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Factors Associated With Increased Hospital Length of Stay in Peritoneal Dialysis Patients With Peritonitis: A Need for Antimicrobial Stewardship?

Authors:  Taylor Morrisette; Robert B Canada; Danielle Padgett; Joanna Q Hudson
Journal:  Hosp Pharm       Date:  2018-12-07

Review 3.  Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.

Authors:  Siegbert Rieg; Marc Fabian Küpper
Journal:  Infection       Date:  2016-02-23       Impact factor: 3.553

4.  Do hospitals need oncological critical care units?

Authors:  Abby Koch; William Checkley
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

5.  Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.

Authors:  Miki Nagao; Masaki Yamamoto; Yasufumi Matsumura; Isao Yokota; Shunji Takakura; Satoshi Teramukai; Satoshi Ichiyama
Journal:  Infection       Date:  2016-10-05       Impact factor: 3.553

6.  Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIV.

Authors:  Andrej Spec; Margaret A Olsen; Krunal Raval; William G Powderly
Journal:  Clin Infect Dis       Date:  2016-12-07       Impact factor: 9.079

7.  Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.

Authors:  Takeshi Kimura; Atsushi Uda; Tomoyuki Sakaue; Kazuhiko Yamashita; Tatsuya Nishioka; Sho Nishimura; Kei Ebisawa; Manabu Nagata; Goh Ohji; Tatsuya Nakamura; Chihiro Koike; Mari Kusuki; Takeshi Ioroi; Akira Mukai; Yasuhisa Abe; Hiroyuki Yoshida; Midori Hirai; Soichi Arakawa; Ikuko Yano; Kentaro Iwata; Issei Tokimatsu
Journal:  Infection       Date:  2017-11-13       Impact factor: 3.553

8.  Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy.

Authors:  Kimberly G Blumenthal; Robert A Parker; Erica S Shenoy; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2015-05-19       Impact factor: 9.079

9.  Antibiotic Utilization and the Role of Suspected and Diagnosed Mosquito-borne Illness Among Adults and Children With Acute Febrile Illness in Pune, India.

Authors:  Matthew L Robinson; Dileep Kadam; Anju Kagal; Sandhya Khadse; Aarti Kinikar; Chhaya Valvi; Anita Basavaraj; Renu Bharadwaj; Ivan Marbaniang; Savita Kanade; Priyanka Raichur; Jonathan Sachs; Eili Klein; Sara Cosgrove; Amita Gupta; Vidya Mave
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

10.  Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting.

Authors:  Shaili Adani; Tanaya Bhowmick; Melvin P Weinstein; Navaneeth Narayanan
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.